zoetis zts - Search News

Zoetis, In-Line Q4

Zoetis (ZTS) Q4 2024 Earnings Call Transcript

Welcome to the fourth-quarter and full-year 2024 financial results conference call and webcast for Zoetis. Hosting the call today is Steve Frank, vice

Seeking Alpha · 1d

Zoetis: In-Line Q4 Earnings And Weak Guidance Present A Buying Opportunity

Zoetis' Q4 earnings met expectations, but the stock fell due to slowing growth and cautious 2025 guidance. Click here to find out why I rate ZTS stock a Buy.

ETF Daily News · 9d

Zoetis (ZTS) to Release Earnings on Thursday

Zoetis (NYSE:ZTS – Get Free Report) is expected to issue its quarterly earnings data before the market opens on Thursday, February 13th. Analysts expect the company to announce earnings of $1.37 per share and revenue of $2.

Zoetis Gets Conditional License From USDA

Reuters · 17h

US gives conditional nod to Zoetis' bird flu vaccine for poultry

The U.S. Department of Agriculture has given a conditional approval to Zoetis to use its bird flu vaccine in poultry, the animal healthcare company said on Friday.

Business Insider · 21h

Zoetis reports conditional license from USDA for Avian Influenza Vaccine

Zoetis (ZTS) announced that the U.S. Department of Agriculture, Center for Veterinary Biologics, has issued the company a conditional license

MarketWatch · 20h

Zoetis Gets Conditional License From USDA for Bird Flu Vaccine

Zoetis said the U.S. Department of Agriculture's Center for Veterinary Biologics issued the company a conditional license for its Avian Influenza Vaccine, H5N2 Subtype, Killed Virus. The vaccine is labeled for use in chickens, the company said.

17hon MSN

Why Zoetis Stock Took Another Tumble Today

One day after unveiling quarterly results that disappointed the market and engendered a stock sell-off, Zoetis (NYSE: ZTS) ...

Zoetis price target lowered to $200 from $205 at BofA

BofA lowered the firm’s price target on Zoetis (ZTS) to $200 from $205 and keeps a Buy rating on the shares. Zoetis reported “solid” Q4 results ...

Why Zoetis Stock Was Falling Today

Shares of Zoetis (NYSE: ZTS), the leading animal pharmaceutical company, were sliding today after its 2025 guidance came up ...

Zoetis (NYSE:ZTS) Price Target Lowered to $200.00 at Piper Sandler

Zoetis (NYSE:ZTS – Get Free Report) had its price objective lowered by analysts at Piper Sandler from $210.00 to $200.00 in a research note issued to investors on Monday,Benzinga reports. The ...

Zoetis Inc. (ZTS) Q4 2024 Earnings Call Transcript

Q4 2024 Earnings Conference Call February 13, 2025 8:30 AM ETCompany ParticipantsSteve Frank - IRKristin Peck - CEOWetteny Joseph ...

Yahoo Finance2d

Zoetis Inc. (ZTS)

Let's examine three of my favorite dividend growth stocks -- ASML (NASDAQ: ASML), Wingstop (NASDAQ: WING), and Zoetis (NYSE: ZTS) -- and discuss what sets them apart from the crowd.

Morgan Stanley Keeps Their Buy Rating on Zoetis (ZTS)

In a report released today, Erin Wright from Morgan Stanley maintained a Buy rating on Zoetis (ZTS – Research Report), with a price target of ...

in.investing.com on MSN2d

Zoetis shares tumble as 2025 guidance falls short of expectations

Zoetis Inc. reported fourth-quarter earnings that narrowly beat analyst estimates, but its shares fell sharply as the animal health company's 2025 guidance came in below Wall Street expectations.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results